Integrated Management of Pronation Deformity in Cerebral Palsy

• Status: Completed
• Trial end date: 2020-03-30
• Target enrollment: 0
• Participant gender: All

Summary

Pronation deformity is a very common problem in children with cerebral palsy. This deformity is usually has neural and non-neural aspects. In this clinical trial the aim is to show the importance of combine treatment approach with pharmacological and non-pharmacological modalities. .

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kocaeli University
• Treatments: abobotulinumtoxinA; Botulinum Toxins; Botulinum Toxins, Type A; onabotulinumtoxinA

Criteria

Inclusion Criteria:

• Diagnosis of cerebral palsy

• MAS score of pronator muscles at least 2

• Gross Motor Functional Classification Scale level of I-IV

• Scheduled to receive botulinum toxin injections to pronator teres and/or -pronator quadratus muscles besides other spastic upper extremity muscles

Exclusion Criteria:

• Severe cognitive or behavioural problems

• Less than 40 degrees of available passive range of motion in pronation

• Severe dystonia in the affected upper limb

• Received orthopedic surgery to affected upper limb